Investigators surveyed 16 private payers to learn their views on coverage for confirmatory diagnostics after a positive, noncovered MCED test.
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Centers for Medicare & Medicaid Services’ (CMS) ...
Utilization management criteria influence patients’ access to specialty drugs, yet the processes used by health plans to establish these criteria are not well understood. This study examined the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results